Genzyme injects E130m into Irish operations:
This article was originally published in Clinica
Executive Summary
Genzyme is to invest E130m ($203m) in its Irish manufacturing facilities. The Cambridge, Massachusetts-based $3.8bn pharma and diagnostics company described its plans to "significantly increase the capacity [of its] sterile finish/manufacturing operation" in Waterford over the next three years as "strategically important for Genzyme Ireland in terms of its overall position in the corporation".